Home Cart 0 Sign in  
X

[ CAS No. 38940-62-4 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 38940-62-4
Chemical Structure| 38940-62-4
Chemical Structure| 38940-62-4
Structure of 38940-62-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 38940-62-4 ]

Related Doc. of [ 38940-62-4 ]

Alternatived Products of [ 38940-62-4 ]

Product Details of [ 38940-62-4 ]

CAS No. :38940-62-4 MDL No. :MFCD03086033
Formula : C7H6BrNO Boiling Point : -
Linear Structure Formula :- InChI Key :LDBPZEQZCOUYFT-UHFFFAOYSA-N
M.W :200.03 Pubchem ID :820423
Synonyms :

Calculated chemistry of [ 38940-62-4 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.14
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 42.13
TPSA : 29.96 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.65 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.64
Log Po/w (XLOGP3) : 1.23
Log Po/w (WLOGP) : 2.05
Log Po/w (MLOGP) : 0.89
Log Po/w (SILICOS-IT) : 2.33
Consensus Log Po/w : 1.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.23
Solubility : 1.17 mg/ml ; 0.00585 mol/l
Class : Soluble
Log S (Ali) : -1.46
Solubility : 6.99 mg/ml ; 0.0349 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.22
Solubility : 0.121 mg/ml ; 0.000605 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.48

Safety of [ 38940-62-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 38940-62-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 38940-62-4 ]
  • Downstream synthetic route of [ 38940-62-4 ]

[ 38940-62-4 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 75-16-1 ]
  • [ 183608-47-1 ]
  • [ 38940-62-4 ]
YieldReaction ConditionsOperation in experiment
88% at -78 - 20℃; for 2 h; To a solution of 5-bromo-N-methoxy-N-methyl-nicotinamide (2.08 g, 8.5 mmol) in THF (20 mL) was added MeMgBr (1.52 g, 12.75 mmol) at −78° C. After the addition, the reaction mixture was stirred at room temperature for 2 hours before quenching with water. After extraction with EtOAC, the organic layer was washed with brine, dried over anhydrous Na2SO4, filtered and concentrated in vacuo. The residue was then purified by flash column chromatography to afford the title compound (1.5 g, 88percent).
88% at -78 - 20℃; [B] 1 -(5-Bromo-pyridin-3-yl)-ethanoneTo a solution of 5-bromo-N-methoxy-N-methyl-nicotinamide (2.08 g, 8.5 mmol) in THF (20 mL) was added MeMgBr (1.52 g, 12.75 mmol) at -78 °C. After the addition, the reaction mixture was stirred at room temperature for 2 hours before quenching with water. After extraction with EtOAC, the organic layer was washed with brine, dried over anhydrous Na2S04, filtered and concentrated in vacuo. The residue was then purified by flash column chromatography to afford the title compound (1.5 g, 88percent).
Reference: [1] Patent: US2013/72679, 2013, A1, . Location in patent: Paragraph 0893; 0894
[2] Patent: WO2013/37779, 2013, A1, . Location in patent: Page/Page column 235; 236
  • 2
  • [ 39620-02-5 ]
  • [ 105-53-3 ]
  • [ 38940-62-4 ]
Reference: [1] Patent: EP1533304, 2005, A1, . Location in patent: Page/Page column 18
[2] Patent: US5026702, 1991, A,
  • 3
  • [ 39620-02-5 ]
  • [ 75-16-1 ]
  • [ 38940-62-4 ]
Reference: [1] Patent: WO2009/10530, 2009, A1, . Location in patent: Page/Page column 89
  • 4
  • [ 20986-40-7 ]
  • [ 38940-62-4 ]
Reference: [1] Patent: US2003/96829, 2003, A1,
  • 5
  • [ 20986-40-7 ]
  • [ 75-16-1 ]
  • [ 38940-62-4 ]
Reference: [1] Patent: US2004/102472, 2004, A1, . Location in patent: Page 32
  • 6
  • [ 20826-04-4 ]
  • [ 38940-62-4 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2381,2383
[2] Patent: WO2013/37779, 2013, A1,
[3] Patent: US2013/72679, 2013, A1,
  • 7
  • [ 59-67-6 ]
  • [ 38940-62-4 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2381,2383
  • 8
  • [ 39620-02-5 ]
  • [ 38940-62-4 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2381,2383
  • 9
  • [ 20986-40-7 ]
  • [ 141-78-6 ]
  • [ 38940-62-4 ]
Reference: [1] Journal of the American Chemical Society, 1948, vol. 70, p. 2381,2383
  • 10
  • [ 38940-62-4 ]
  • [ 142337-95-9 ]
YieldReaction ConditionsOperation in experiment
65% With sodium hydroxide; hydrazine In diethylene glycol at 140℃; for 6 h; Sodium hydroxide (10g, 0.25 mol) and hydrazine monohydrate (10ML) were added to a solution of 3-acetyl-5-bromopyridine (5g, 25 mmol) dissolved in diethylene glycol (18mL). The reaction mixture was heated to 140 C for 6 hours and then partitioned between H2O and Ether. The organic layers were washed with brine, dried over MGS04 and concentrated. The residue was purified by flash silica gel chromatography (0percent to 40percent EtOAc in hexanes) to give the title compound (3 g, 65percent). 1H NMR (400 MHz, CDCI3) : 6 1.26 (t, J=7. 6 Hz, 3 H), 2.65 (q, J=7.6 Hz, 2 H), 7.67 (s, 1H), 8.37 (s, 1 H), 8.51 (s, 1 H).
58% With sodium hydroxide; hydrazine In diethylene glycol at 140℃; for 6 h; A mixture of NaOH (10 g, 0.25 mol), hydrazine monohydrate (10 mL) and 3-acetyl-5-bromopyridine (5g, 25 mmol) suspended in diethylene glycol (18 mL) was heated to 140 °C for 6 hours. The mixture was cooled to room temperature and partitioned between H2O and ether. The ether extracts were dried over MgSO4 and concentrated to a clear oil. Flash column chromatography (0percent to 15percent EtOAc in hexanes) gave the product as a clear oil (2.9 g, 58percent). 1H NMR (400 MHz, CDCI3): 5 1.26 (t, J=7.6 Hz, 3 H), 2.65 (d, J=7.6 Hz, 2 H), 7.67 (t, J=2.0 Hz, 1 H), 8.37 (d, J=1.8 Hz, 1 H), 8.51 (d, J=2.0 Hz, 1 H).
Reference: [1] Tetrahedron, 1992, vol. 48, # 31, p. 6445 - 6454
[2] Patent: WO2004/74270, 2004, A2, . Location in patent: Page 261
[3] Patent: WO2006/18725, 2006, A1, . Location in patent: Page/Page column 117
[4] Patent: WO2007/84560, 2007, A2, . Location in patent: Page/Page column 168-169
  • 11
  • [ 38940-62-4 ]
  • [ 1108724-32-8 ]
YieldReaction ConditionsOperation in experiment
36% With (bis-(2-methoxyethyl)amino)sulfur trufluoride In dichloromethane at 60℃; Sealed tube Heat the mixture of l-(5-bromopyridin-3-yl)ethanone (500 mg, 2.5 mmol), bis-(2-methoxyethyl)aminosulfur trifluoride (BAST, 2.2 g, 10 mmol) in dichloromethane (8 mL) in a sealed tube at 60°C overnight. TLC (PE:EtOAc=l :l) shows the reaction is complete. Concentrate the mixture, purify the residue by flash chromatography (silica gel, PE:EtOAc=l :1) to afford the title compound (200 mg, 36percent). MS: (M+1): 222/224.
36% With (bis-(2-methoxyethyl)amino)sulfur trufluoride In dichloromethane at 60℃; Sealed tube Heat the mixture of 1-(5-bromopyridin-3-yl)ethanone (500 mg, 2.5 mmol), bis-(2-methoxyethyl)aminosulfur trifluoride (BAST, 2.2 g, 10 mmol) in dichloromethane (8 mL) in a sealed tube at 60° C. overnight. TLC (PE:EtOAc=1:1) shows the reaction is complete.
Concentrate the mixture, purify the residue by flash chromatography (silica gel, PE:EtOAc=1:1) to afford the title compound (200 mg, 36percent). MS: (M+1): 222/224.
Reference: [1] Patent: WO2014/418, 2014, A1, . Location in patent: Page/Page column 56
[2] Patent: US2015/197511, 2015, A1, . Location in patent: Paragraph 0275; 0276
[3] Patent: WO2015/138220, 2015, A1, . Location in patent: Page/Page column 87
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 38940-62-4 ]

Bromides

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.93

Chemical Structure| 59105-50-9

[ 59105-50-9 ]

(5-Bromopyridin-3-yl)(phenyl)methanone

Similarity: 0.90

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.82

Chemical Structure| 84199-61-1

[ 84199-61-1 ]

3-Acetyl-2-bromopyridine

Similarity: 0.80

Chemical Structure| 886365-47-5

[ 886365-47-5 ]

1-(5-Bromo-2-chloropyridin-3-yl)ethanone

Similarity: 0.79

Ketones

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.93

Chemical Structure| 59105-50-9

[ 59105-50-9 ]

(5-Bromopyridin-3-yl)(phenyl)methanone

Similarity: 0.90

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.82

Chemical Structure| 84199-61-1

[ 84199-61-1 ]

3-Acetyl-2-bromopyridine

Similarity: 0.80

Chemical Structure| 350-03-8

[ 350-03-8 ]

1-(Pyridin-3-yl)ethanone

Similarity: 0.79

Related Parent Nucleus of
[ 38940-62-4 ]

Pyridines

Chemical Structure| 1256823-89-8

[ 1256823-89-8 ]

1-(5-Bromo-2-methylpyridin-3-yl)ethanone

Similarity: 0.93

Chemical Structure| 59105-50-9

[ 59105-50-9 ]

(5-Bromopyridin-3-yl)(phenyl)methanone

Similarity: 0.90

Chemical Structure| 1883347-28-1

[ 1883347-28-1 ]

1-(5-Bromopyridin-3-yl)-2,2,2-trifluoroethanone hydrochloride

Similarity: 0.82

Chemical Structure| 84199-61-1

[ 84199-61-1 ]

3-Acetyl-2-bromopyridine

Similarity: 0.80

Chemical Structure| 350-03-8

[ 350-03-8 ]

1-(Pyridin-3-yl)ethanone

Similarity: 0.79